Eric Laifman1, Thomas G Keens1,2, Yaniv Bar-Cohen1,2, Iris A Perez3,4. 1. Children's Hospital Los Angeles, Los Angeles, CA, USA. 2. Keck School of Medicine of USC, Los Angeles, CA, USA. 3. Children's Hospital Los Angeles, Los Angeles, CA, USA. iaperez@chla.usc.edu. 4. Keck School of Medicine of USC, Los Angeles, CA, USA. iaperez@chla.usc.edu.
Abstract
Congenital central hypoventilation syndrome (CCHS) patients are at risk for life-threatening cardiac arrhythmias, and presentation is dependent on their PHOX2B gene mutation. We describe the presentation of life-threatening arrhythmias in our cohort of CCHS patients. We reviewed the records of 72 CCHS patients seen at CHLA from 2004 to 2018. Data collected included demographics, PHOX2B genotype, ventilatory support, clinical symptoms, ambulatory cardiac monitoring results, and presence of cardiac pacemaker. Sixteen of 72 patients had evidence of potential life-threatening cardiac arrhythmias. PHOX2B genotypes were 20/25 polyalanine repeat expansion mutation (PARM), 20/26 PARM, 20/27 PARM, 20/32 PARM, and c.245C > T non-polyalanine repeat mutation. 11/16 patients were ventilated during sleep only. Symptoms included syncope, dizziness, chest pain, tingling in the left arm, and palpitations. 15/16 patients had recorded ambulatory cardiac monitoring. 5/16 patients were symptomatic without significant sinus pauses. 12/16 patients had implantation of cardiac pacemakers. 9/12 had significant sinus pauses on ambulatory monitoring, and 7/12 patients were symptomatic. Conclusion: CCHS patients have potential life-threatening arrhythmias requiring cardiac pacemaker implantation. Many of these patients are symptomatic with significant sinus pauses on ambulatory monitoring. However, some symptomatic patients with no significant pauses on ambulatory monitoring may still require cardiac pacemaker implantation.What is Known:• CCHS patients are at risk for life-threatening sinus pauses and require cardiac pacemaker implantation.What is New:• CCHS patients regardless of PHOX2B genotype are at risk for significant sinus pauses. Many CCHS patients with significant sinus pause on ambulatory cardiac monitoring are symptomatic and most present with syncope. Some symptomatic patients do not have significant sinus pauses but may still require cardiac pacemaker implantation.
Congenital central hypoventilation syndrome (CCHS) patients are at risk for life-threatening cardiac arrhythmias, and presentation is dependent on their PHOX2B gene mutation. We describe the presentation of life-threatening arrhythmias in our cohort of CCHSpatients. We reviewed the records of 72 CCHSpatients seen at CHLA from 2004 to 2018. Data collected included demographics, PHOX2B genotype, ventilatory support, clinical symptoms, ambulatory cardiac monitoring results, and presence of cardiac pacemaker. Sixteen of 72 patients had evidence of potential life-threatening cardiac arrhythmias. PHOX2B genotypes were 20/25 polyalanine repeat expansion mutation (PARM), 20/26 PARM, 20/27 PARM, 20/32 PARM, and c.245C > T non-polyalanine repeat mutation. 11/16 patients were ventilated during sleep only. Symptoms included syncope, dizziness, chest pain, tingling in the left arm, and palpitations. 15/16 patients had recorded ambulatory cardiac monitoring. 5/16 patients were symptomatic without significant sinus pauses. 12/16 patients had implantation of cardiac pacemakers. 9/12 had significant sinus pauses on ambulatory monitoring, and 7/12 patients were symptomatic. Conclusion:CCHSpatients have potential life-threatening arrhythmias requiring cardiac pacemaker implantation. Many of these patients are symptomatic with significant sinus pauses on ambulatory monitoring. However, some symptomatic patients with no significant pauses on ambulatory monitoring may still require cardiac pacemaker implantation.What is Known:• CCHSpatients are at risk for life-threatening sinus pauses and require cardiac pacemaker implantation.What is New:• CCHSpatients regardless of PHOX2B genotype are at risk for significant sinus pauses. Many CCHSpatients with significant sinus pause on ambulatory cardiac monitoring are symptomatic and most present with syncope. Some symptomatic patients do not have significant sinus pauses but may still require cardiac pacemaker implantation.
Authors: Nick A Antic; Beth A Malow; Neale Lange; R Doug McEvoy; Amy L Olson; Peter Turkington; Wolfram Windisch; Martin Samuels; Cathy A Stevens; Elizabeth M Berry-Kravis; Debra E Weese-Mayer Journal: Am J Respir Crit Care Med Date: 2006-07-27 Impact factor: 21.405
Authors: Debra E Weese-Mayer; Elizabeth M Berry-Kravis; Isabella Ceccherini; Thomas G Keens; Darius A Loghmanee; Ha Trang Journal: Am J Respir Crit Care Med Date: 2010-03-15 Impact factor: 21.405
Authors: Paul M Macey; Claire Valderama; Amy H Kim; Mary A Woo; David Gozal; Thomas G Keens; Rebecca K Harper; Ronald M Harper Journal: Pediatr Res Date: 2004-03-17 Impact factor: 3.756
Authors: André Diedrich; Beth A Malow; Nick A Antic; Kyoko Sato; R Doug McEvoy; Christopher J Mathias; David Robertson; Elizabeth M Berry-Kravis; Debra E Weese-Mayer Journal: Clin Auton Res Date: 2007-05-31 Impact factor: 4.435
Authors: Ilan Ruhr; Jacob Bierstedt; Turk Rhen; Debojyoti Das; Sunil Kumar Singh; Soleille Miller; Dane A Crossley; Gina L J Galli Journal: Epigenetics Chromatin Date: 2021-09-06 Impact factor: 4.954
Authors: Ajay S Kasi; Hong Li; Kelli-Lee Harford; Humphrey V Lam; Chad Mao; April M Landry; Sarah G Mitchell; Matthew S Clifton; Roberta M Leu Journal: J Multidiscip Healthc Date: 2022-03-08
Authors: Ha Trang; Martin Samuels; Isabella Ceccherini; Matthias Frerick; Maria Angeles Garcia-Teresa; Jochen Peters; Johannes Schoeber; Marek Migdal; Agneta Markstrom; Giancarlo Ottonello; Raffaele Piumelli; Maria Helena Estevao; Irena Senecic-Cala; Barbara Gnidovec-Strazisar; Andreas Pfleger; Raquel Porto-Abal; Miriam Katz-Salamon Journal: Orphanet J Rare Dis Date: 2020-09-21 Impact factor: 4.123
Authors: Marta Ditmer; Szymon Turkiewicz; Agata Gabryelska; Marcin Sochal; Piotr Białasiewicz Journal: Int J Environ Res Public Health Date: 2021-12-20 Impact factor: 3.390